Investigating the Acute Effects of Increasing Alanine Exposure in Healthy Participants

In this study the investigators will investigate the acute effects of increasing alanine exposure on metabolic parameters in healthy participants. Participants will participate in one study day. After initial baseline blood samples, a three-hour intravenous infusion with glucagon will be initiated. The infusion rate will be increased every 30 minutes.

NCT Number	NCT07350512
Lead Sponsor	Nicolai Jacob Wewer Albrechtsen
Conditions	Glucose Metabolism, Glucagon
Enrollment	15 participants
Start Date	2026-01-20
Primary Completion	2026-09-30 (estimated)
Study Completion	2027-01-20 (estimated)
Updated on ClinicalTrials.gov	2026-01-20